S

SLS

SELLAS Life Sciences Group Inc

12.48

Jul 20 • 03:59PM ET -0.71 (-5.42%)

12.47

Aftermarket • 07:59PM ET -0.01 (-0.04%)

Healthcare Biotechnology USA Mid NASD

Peers: IDYA TNGX CGON RCUS NUVL BMRN KYMR RYTM INCY KRYS

| Held by: XBI VTI IWM VXF IWO VTWO IWC VHT DWAS LABU

Scroll to Statements

Index	RUT
Market Cap	2.32B
Enterprise Value	2.21B
Income	-29.46M
Sales	0.00M
Book/sh	0.59
Cash/sh	0.58
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Mar 24, 2011
Dividend Gr. 3/5Y	- -
Payout	-
Employees	13
IPO	Mar 12, 2008

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	21.06
P/C	21.65
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	17.22
Current Ratio	17.22
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.23
EPS next Y	-0.12
EPS next Q	-0.04
EPS this Y	16.00%
EPS next Y	40.48%
EPS next 5Y	-
EPS past 3/5Y	51.28% 34.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	41.60%
Sales Y/Y TTM	-
EPS Q/Q	26.44%
Sales Q/Q	-
Earnings	May 12 AMC
EPS/Sales Surpr.	16.67% -

Insider Own	1.21%
Insider Trans	0.00%
Inst Own	29.25%
Inst Trans	9.75%
ROA	-39.50%
ROE	-43.58%
ROIC	-27.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.93%
SMA50	29.95%
SMA200	150.20%
Trades

Shs Outstand	186.03M
Shs Float	183.79M
Short Float	34.45%
Short Ratio	6.72
Short Interest	63.31M
52W High	15.88 -21.42%
52W Low	1.39 797.48%
Volatility	12.28% 12.93%
ATR (14)	1.40
RSI (14)	54.25
Beta	2.47
Rel Volume	0.77
Avg Volume	9.42M
Volume	7,289,646

Perf Week	-1.15%
Perf Month	60.76%
Perf Quarter	138.98%
Perf Half Y	224.87%
Perf YTD	230.90%
Perf Year	604.80%
Perf 3Y	629.53%
Perf 5Y	45.06%
Perf 10Y	-99.91%
Recom	1.00
Target Price	27.50
Prev Close	13.19
Price	12.48
Change	-5.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)